M Ingelmo

15.8k total citations · 2 hit papers
158 papers, 9.2k citations indexed

About

M Ingelmo is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, M Ingelmo has authored 158 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Rheumatology, 32 papers in Immunology and 30 papers in Pathology and Forensic Medicine. Recurrent topics in M Ingelmo's work include Systemic Lupus Erythematosus Research (86 papers), Salivary Gland Disorders and Functions (24 papers) and Systemic Sclerosis and Related Diseases (23 papers). M Ingelmo is often cited by papers focused on Systemic Lupus Erythematosus Research (86 papers), Salivary Gland Disorders and Functions (24 papers) and Systemic Sclerosis and Related Diseases (23 papers). M Ingelmo collaborates with scholars based in Spain, Mexico and United Kingdom. M Ingelmo's co-authors include Ricard Cervera, Josep Font, Manuel Ramos‐Casals, Mario García‐Carrasco, Munther A. Khamashta, Gerard Espinosa, Joan Carles Reverter, Alfonso López‐Soto, Ronald A. Asherson and Gian Domenico Sebastiani and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Kidney International.

In The Last Decade

M Ingelmo

151 papers receiving 8.8k citations

Hit Papers

Morbidity and Mortality i... 1993 2026 2004 2015 2003 1993 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M Ingelmo 6.4k 2.4k 1.8k 1.3k 1.3k 158 9.2k
Josep Font 7.8k 1.2× 3.0k 1.2× 2.1k 1.2× 1.4k 1.1× 2.1k 1.7× 206 11.8k
Gerard Espinosa 5.4k 0.8× 1.8k 0.7× 2.4k 1.4× 1.2k 0.9× 625 0.5× 340 8.8k
Panayiotis G. Vlachoyiannopoulos 5.4k 0.8× 1.8k 0.8× 2.4k 1.4× 865 0.7× 430 0.3× 118 8.2k
G. R. V. Hughes 4.9k 0.8× 1.9k 0.8× 1.9k 1.1× 596 0.5× 337 0.3× 120 6.9k
Gunnar Sturfelt 5.1k 0.8× 4.7k 2.0× 871 0.5× 782 0.6× 488 0.4× 165 8.3k
Robin L. Brey 7.8k 1.2× 2.2k 0.9× 3.6k 2.0× 813 0.6× 234 0.2× 77 10.4k
Ronald A. Asherson 6.4k 1.0× 1.2k 0.5× 2.6k 1.5× 1.2k 1.0× 213 0.2× 155 8.1k
B. Wechsler 4.7k 0.7× 1.5k 0.6× 1.1k 0.6× 2.8k 2.2× 1.7k 1.4× 277 10.2k
Pilar Brito‐Zerón 3.3k 0.5× 1.9k 0.8× 1.1k 0.6× 1.1k 0.9× 3.2k 2.6× 120 8.8k
Marta Mosca 4.4k 0.7× 2.5k 1.0× 489 0.3× 1.1k 0.9× 851 0.7× 311 7.7k

Countries citing papers authored by M Ingelmo

Since Specialization
Citations

This map shows the geographic impact of M Ingelmo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Ingelmo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Ingelmo more than expected).

Fields of papers citing papers by M Ingelmo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Ingelmo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Ingelmo. The network helps show where M Ingelmo may publish in the future.

Co-authorship network of co-authors of M Ingelmo

This figure shows the co-authorship network connecting the top 25 collaborators of M Ingelmo. A scholar is included among the top collaborators of M Ingelmo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Ingelmo. M Ingelmo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramos‐Casals, Manuel, Mario García‐Carrasco, Ricard Cervera, Josep Font, & M Ingelmo. (2005). Significado clínico de las alteraciones analíticas en el síndrome de Sjögren. 29(7). 343–355. 1 indexed citations
2.
Cervera, Ricard, Josep Font, José A. Gómez‐Puerta, et al.. (2005). Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Annals of the Rheumatic Diseases. 64(8). 1205–1209. 163 indexed citations
3.
Brito‐Zerón, Pilar, Manuel Ramos‐Casals, Norma Nardi, et al.. (2005). Circulating Monoclonal Immunoglobulins in Sjögren Syndrome. Medicine. 84(2). 90–97. 39 indexed citations
4.
Nardi, Norma, Pilar Brito‐Zerón, Manuel Ramos‐Casals, et al.. (2005). Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome. Clinical Rheumatology. 25(3). 341–346. 71 indexed citations
5.
Cervera, Ricard, Munther A. Khamashta, Josep Font, et al.. (2003). Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period. Medicine. 82(5). 299–308. 987 indexed citations breakdown →
6.
García‐Carrasco, Mario, Antoni Sisó‐Almirall, Manuel Ramos‐Casals, et al.. (2002). Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients.. PubMed. 29(4). 726–30. 46 indexed citations
7.
Espinosa, Gerard, Josep Font, Dolors Tàssies, et al.. (2002). Vascular involvement in Behçet’s disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. The American Journal of Medicine. 112(1). 37–43. 124 indexed citations
8.
Ramos‐Casals, Manuel, Mario García‐Carrasco, Ricard Cervera, et al.. (2001). Hepatitis C Virus Infection Mimicking Primary Sjögren Syndrome. Medicine. 80(1). 1–8. 117 indexed citations
9.
Espinosa, Gerard, Dolors Tàssies, Josep Font, et al.. (2001). Antiphospholipid antibodies and thrombophilic factors in giant cell arteritis. Seminars in Arthritis and Rheumatism. 31(1). 12–20. 38 indexed citations
10.
Espinosa, Gerard, Josep Font, Juan Carlos García‐Pagán, et al.. (2001). Budd-Chiari Syndrome Secondary to Antiphospholipid Syndrome. Medicine. 80(6). 345–354. 54 indexed citations
11.
Cervera, Ricard, Munther A. Khamashta, Josep Font, et al.. (1999). Morbidity and Mortality in Systemic Lupus Erythematosus During a 5-Year Period: A Multicenter Prospective Study of 1,000 Patients. Medicine. 78(3). 167–175. 315 indexed citations
12.
Morlà, Rosa, Manuel Ramos‐Casals, Mario García‐Carrasco, et al.. (1999). Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus. 8(2). 160–163. 30 indexed citations
13.
Asherson, Ronald A., Ricard Cervera, Jean‐Charles Piette, et al.. (1998). Catastrophic Antiphospholipid Syndrome: Clinical and Laboratory Features of 50 Patients. Medicine. 77(3). 195–207. 369 indexed citations
14.
Reverter, Joan Carles, Dolors Tàssies, Josep Font, et al.. (1998). Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis & Rheumatism. 41(8). 1420–1427. 84 indexed citations
15.
Font, José A., Dolors Tàssies, Mario García‐Carrasco, et al.. (1998). Hepatitis G virus infection in primary Sjögren’s syndrome: analysis in a series of 100 patients. Annals of the Rheumatic Diseases. 57(1). 42–44. 17 indexed citations
16.
Teixidó, Montserrat, Josep Font, Joan Carles Reverter, et al.. (1997). Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome. Lara D. Veeken. 36(1). 113–116. 30 indexed citations
17.
Cervera, Ricard, Munther A. Khamashta, Josep Font, et al.. (1993). Systemic Lupus Erythematosus. Medicine. 72(2). 113–124. 706 indexed citations breakdown →
18.
Sobrino, José A., et al.. (1991). Prosthetic valve endocarditis caused by corynebacterium pilosum. Infection. 19(4). 247–249. 3 indexed citations
19.
López‐Soto, Alejandro, et al.. (1989). Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen. Thrombosis Research. 53(6). 623–628. 7 indexed citations
20.
Sierra, Alejandro de la, et al.. (1989). Clinical Profiles and erythrocyte Na+ transport abnormalities of four major types of primary hypertension in Spain. Kidney International. 36(1). 114–119. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026